AHR

AHR
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $572.937M ▲ | $75.931M ▲ | $55.927M ▲ | 9.761% ▲ | $0.33 ▲ | $84.728M ▼ |
| Q2-2025 | $542.503M ▲ | $69.874M ▲ | $9.908M ▲ | 1.826% ▲ | $0.062 ▲ | $84.781M ▲ |
| Q1-2025 | $540.603M ▼ | $67.912M ▼ | $-6.804M ▲ | -1.259% ▲ | $-0.043 ▲ | $67.639M ▲ |
| Q4-2024 | $542.74M ▲ | $72.018M ▲ | $-31.773M ▼ | -5.854% ▼ | $-0.21 ▼ | $55.419M ▼ |
| Q3-2024 | $523.814M | $69.317M | $-4.126M | -0.788% | $-0.031 | $81.465M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $147.364M ▲ | $4.77B ▲ | $2.05B ▲ | $2.678B ▲ |
| Q2-2025 | $133.494M ▲ | $4.507B ▲ | $2.044B ▼ | $2.421B ▲ |
| Q1-2025 | $86.064M ▲ | $4.464B ▼ | $2.159B ▼ | $2.262B ▲ |
| Q4-2024 | $76.702M ▲ | $4.488B ▼ | $2.184B ▼ | $2.261B ▲ |
| Q3-2024 | $67.85M | $4.677B | $2.42B | $2.207B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $56.639M ▲ | $107.185M ▲ | $-278.457M ▼ | $185.691M ▲ | $14.372M ▼ | $155.262M ▲ |
| Q2-2025 | $10.079M ▲ | $71.475M ▲ | $-62.086M ▼ | $33.124M ▲ | $42.538M ▲ | $44.579M ▲ |
| Q1-2025 | $-6.84M ▲ | $60.616M ▲ | $-32.776M ▼ | $-23.776M ▲ | $4.152M ▼ | $39.435M ▲ |
| Q4-2024 | $-32.429M ▼ | $59.509M ▼ | $87.207M ▲ | $-139.982M ▼ | $6.629M ▼ | $29.825M ▼ |
| Q3-2024 | $-3.093M | $63.13M | $-30.407M | $-13.696M | $19.07M | $39.249M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
Resident Fees and Services | $950.00M ▲ | $500.00M ▼ | $500.00M ▲ | $530.00M ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
American Healthcare REIT shows a clear growth pattern in revenue and improving underlying operating performance, but it is still reporting accounting losses and operates with a leveraged, capital‑heavy balance sheet. The integrated senior campus model, supported by the Trilogy platform, provides a distinct strategic angle and could offer durable advantages in resident retention and operational control. Cash generation has been moving in the right direction, though with a relatively thin buffer after investment needs. Overall, the company looks like a scaling healthcare REIT with a differentiated model and better fundamentals than a few years ago, but with ongoing execution, financing, and regulatory risks that are typical for this sector and its stage of development as a newly public entity.
NEWS
November 20, 2025 · 11:05 PM UTC
American Healthcare REIT Announces Pricing of Public Offering of Common Stock
Read more
November 20, 2025 · 4:01 PM UTC
American Healthcare REIT Announces Public Offering of Common Stock
Read more
November 6, 2025 · 4:15 PM UTC
American Healthcare REIT ("AHR") Announces Third Quarter 2025 Results; Increases Full Year 2025 Guidance
Read more
October 1, 2025 · 4:15 PM UTC
American Healthcare REIT Announces Dates for Third Quarter 2025 Earnings Release and Conference Call
Read more
September 18, 2025 · 4:15 PM UTC
American Healthcare REIT Declares Third Quarter 2025 Distribution
Read more
About American Healthcare REIT, Inc.
https://www.americanhealthcarereit.comFormed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $572.937M ▲ | $75.931M ▲ | $55.927M ▲ | 9.761% ▲ | $0.33 ▲ | $84.728M ▼ |
| Q2-2025 | $542.503M ▲ | $69.874M ▲ | $9.908M ▲ | 1.826% ▲ | $0.062 ▲ | $84.781M ▲ |
| Q1-2025 | $540.603M ▼ | $67.912M ▼ | $-6.804M ▲ | -1.259% ▲ | $-0.043 ▲ | $67.639M ▲ |
| Q4-2024 | $542.74M ▲ | $72.018M ▲ | $-31.773M ▼ | -5.854% ▼ | $-0.21 ▼ | $55.419M ▼ |
| Q3-2024 | $523.814M | $69.317M | $-4.126M | -0.788% | $-0.031 | $81.465M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $147.364M ▲ | $4.77B ▲ | $2.05B ▲ | $2.678B ▲ |
| Q2-2025 | $133.494M ▲ | $4.507B ▲ | $2.044B ▼ | $2.421B ▲ |
| Q1-2025 | $86.064M ▲ | $4.464B ▼ | $2.159B ▼ | $2.262B ▲ |
| Q4-2024 | $76.702M ▲ | $4.488B ▼ | $2.184B ▼ | $2.261B ▲ |
| Q3-2024 | $67.85M | $4.677B | $2.42B | $2.207B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $56.639M ▲ | $107.185M ▲ | $-278.457M ▼ | $185.691M ▲ | $14.372M ▼ | $155.262M ▲ |
| Q2-2025 | $10.079M ▲ | $71.475M ▲ | $-62.086M ▼ | $33.124M ▲ | $42.538M ▲ | $44.579M ▲ |
| Q1-2025 | $-6.84M ▲ | $60.616M ▲ | $-32.776M ▼ | $-23.776M ▲ | $4.152M ▼ | $39.435M ▲ |
| Q4-2024 | $-32.429M ▼ | $59.509M ▼ | $87.207M ▲ | $-139.982M ▼ | $6.629M ▼ | $29.825M ▼ |
| Q3-2024 | $-3.093M | $63.13M | $-30.407M | $-13.696M | $19.07M | $39.249M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
Resident Fees and Services | $950.00M ▲ | $500.00M ▼ | $500.00M ▲ | $530.00M ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
American Healthcare REIT shows a clear growth pattern in revenue and improving underlying operating performance, but it is still reporting accounting losses and operates with a leveraged, capital‑heavy balance sheet. The integrated senior campus model, supported by the Trilogy platform, provides a distinct strategic angle and could offer durable advantages in resident retention and operational control. Cash generation has been moving in the right direction, though with a relatively thin buffer after investment needs. Overall, the company looks like a scaling healthcare REIT with a differentiated model and better fundamentals than a few years ago, but with ongoing execution, financing, and regulatory risks that are typical for this sector and its stage of development as a newly public entity.
NEWS
November 20, 2025 · 11:05 PM UTC
American Healthcare REIT Announces Pricing of Public Offering of Common Stock
Read more
November 20, 2025 · 4:01 PM UTC
American Healthcare REIT Announces Public Offering of Common Stock
Read more
November 6, 2025 · 4:15 PM UTC
American Healthcare REIT ("AHR") Announces Third Quarter 2025 Results; Increases Full Year 2025 Guidance
Read more
October 1, 2025 · 4:15 PM UTC
American Healthcare REIT Announces Dates for Third Quarter 2025 Earnings Release and Conference Call
Read more
September 18, 2025 · 4:15 PM UTC
American Healthcare REIT Declares Third Quarter 2025 Distribution
Read more

CEO
Danny Prosky
Compensation Summary
(Year 2024)

CEO
Danny Prosky
Compensation Summary
(Year 2024)
Ratings Snapshot
Rating : C
Most Recent Analyst Grades

Truist Securities
Buy

Citizens
Market Outperform

JMP Securities
Market Outperform

Citizens Capital Markets
Market Outperform

RBC Capital
Outperform

Scotiabank
Sector Outperform

Keybanc
Overweight

Morgan Stanley
Overweight
Grade Summary
Price Target
Institutional Ownership

VANGUARD GROUP INC
23.53M Shares
$1.195B

BLACKROCK, INC.
18.474M Shares
$938.099M

PRINCIPAL FINANCIAL GROUP INC
8.931M Shares
$453.533M

WELLINGTON MANAGEMENT GROUP LLP
8.659M Shares
$439.684M

STATE STREET CORP
6.877M Shares
$349.216M

INVESCO LTD.
5.355M Shares
$271.904M

BLACKROCK INC.
5.153M Shares
$261.692M

GEODE CAPITAL MANAGEMENT, LLC
4.872M Shares
$247.392M

ALLIANCEBERNSTEIN L.P.
4.859M Shares
$246.762M

PRUDENTIAL FINANCIAL INC
4.069M Shares
$206.616M

FMR LLC
3.554M Shares
$180.496M

CENTERSQUARE INVESTMENT MANAGEMENT LLC
3.103M Shares
$157.562M

AMERICAN CENTURY COMPANIES INC
2.839M Shares
$144.149M

CHARLES SCHWAB INVESTMENT MANAGEMENT INC
2.654M Shares
$134.75M

DEUTSCHE BANK AG\
2.377M Shares
$120.681M

BANK OF AMERICA CORP /DE/
2.127M Shares
$108.001M

NUVEEN ASSET MANAGEMENT, LLC
2.037M Shares
$103.43M

NORTHERN TRUST CORP
1.658M Shares
$84.195M

NUVEEN, LLC
1.599M Shares
$81.215M

GRS ADVISORS, LLC
1.481M Shares
$75.191M
Summary
Only Showing The Top 20

